EDAP TMS S.A.
Research EDAP TMS S.A. (FOCL) on Bullrun: market cap USD 152.55M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFOCL
- ExchangeNASDAQ
- CountryFrance
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyUSD
- Market capUSD 152.55M
- Financial periodQ2 2026
- RevenueUSD 13.20M
- Net income-USD 14.49M
- Free cash flow-USD 4.95M
- Gross margin55.6%
Valuation Snapshot
latest market cap is USD 152.55M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 70.53M | -USD 29.25M | -USD 22.17M | 42.5% | -0.81 | USD 20.45M | USD 27.68M | USD 19.41M |
| FY2024 | USD 69.40M | -USD 20.58M | -USD 19.14M | 41.4% | -0.53 | USD 31.00M | USD 14.46M | USD 42.49M |
| FY2023 | USD 66.79M | -USD 23.41M | -USD 20.97M | 40.4% | -0.63 | USD 48.05M | USD 9.31M | USD 62.92M |
| FY2022 | USD 59.10M | -USD 3.15M | -USD 5.73M | 43.9% | -0.1 | USD 67.71M | USD 10.06M | USD 76.82M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-19 | USD 152.55M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 123.02M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 82.64M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 194.98M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 356.75M | 93.3 | n/a | n/a |
| 2021 | 2021-12-31 | USD 200.46M | 248.5 | n/a | n/a |
About EDAP TMS S.A.
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is EDAP TMS S.A.'s market cap?
EDAP TMS S.A.'s market capitalization is USD 152.55M.
What does EDAP TMS S.A. do?
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. It also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services.